United States · FDA National Drug Code directory
VASOPRESSIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-039_9fa80e75-4058-47f2-be6f-36d33062abd6
- Product NDC
- 65219-039
- Form
- INJECTION, SOLUTION
- Composition / generic term
- VASOPRESSIN
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230526
- Source listing expiry
- 20261231
Source-listed ingredients
- VASOPRESSIN — 20 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, SINGLE-DOSE in 1 TRAY (65219-039-01) / 1 mL in 1 VIAL, SINGLE-DOSE (65219-039-00) · 65219-039-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →